Study of Possible Relation between Fasting plasma Glucagon ,Gestational Diabetes and Development of Type 2 DM.
Women who develop GDM (gestational diabetes mellitus) have a relative insulin secretion deficiency, the severity of which may be predictive for later development of diabetes. The study aimed to investigate the role of fasting plasma glucagon in prediction of later development of diabetes in pregnant ladies with GDM. study was conducted on 150 pregnant ladies with GDM after giving an informed oral and written consents approved by research ethical committee according to declaration of Helsinki, The study was conducted on two phases, first during pregnancy and the second was six months post-partum, as we measured fasting plasma glucagon before and after delivery together with fasting and 2 hour post-prandial plasma sugar, the finding suggested that glucagon levels significantly increased after delivery in the majority 14/25 (56%) of GDM women who developed type 2 DM within 6 months after delivery compared to 6/20 (30%) in patients with impaired fasting plasma glucose (IFG) and only 22/105 (20%) of non DM women as the median glucagon levels were (80,76, 55) respectively and also there was high statistical difference between fasting plasma glucagon post-delivery among diabetic and non-diabetic ladies (p ≤ 0.001 ). These results indicate the useful role of assessing fasting plasma glucagon before and after delivery in patients with GDM to predict the possibility of type 2 DM. there is relatively high glucagon level in GDM patients which is a significant pathogenic factor in the incidence of subsequent diabetes in women with history of GDM. This could be important in the design of follow-up programs for women with previous GDM.